Prostate cancer treatment could be "supercharged" by a new way of weakening malignant cells, say scientists in Australia.

Drugs already in use could be combined to form a two-pronged attack on advanced prostate cancer, a study suggests.

Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

Prostate cancer is the second-leading cause of death in American men. However, prostate cancer is curable, thanks to options ...

Professor Gerhardt Attard from the UCL Cancer Institute and lead author of the study, said: “Although current standard ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

A new study reveals that men with a mutation to the BRCA genes, often known as the ‘Angelina Jolie’ gene because the ...

Prostate cancer is the most common cancer that affects men globally, with an estimated 1.4 million new cases and 375,000 ...

Former President Joe Biden is now receiving radiation therapy for his prostate cancer, a spokesperson for the former ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...